|
Empagliflozin 25 MG Oral Tablet Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since July 2026
Also known as: jardiance
Pipeline
Early 1: 1Phase 4: 1
Top Sponsors
- University of Minnesota1
- The University of Texas Health Science Center at San Antonio1
Indications
- TPIAT1
- Partial Islet Function1
- Heart Failure With Reduced Ejection Fraction1
- Type2diabetes1
- Heart Disease1
Minneapolis, Minnesota1 trial
SGLT2i Therapy in Islet Transplantation (SIT)
University of Minnesota
Phase 4
San Antonio, Texas1 trial
Ketones, SGLT2, HFrEF
Texas Diabetes Institute - University Health System
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.